LY 311727 |
| カタログ番号GC16364 |
LY 311727 は、強力な分泌型非膵臓ホスホリパーゼ A2 (sPLA2) 阻害剤です (グループ IIA sPLA2 の IC50 < 1 μM)。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 164083-84-5
Sample solution is provided at 25 µL, 10mM.
評判の良い論文で引用されたGlpBio製品
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 164083-84-5 | SDF | |
| Chemical Name | (3-((3-(2-amino-2-oxoethyl)-1-benzyl-2-ethyl-1H-indol-5-yl)oxy)propyl)phosphonic acid | ||
| Canonical SMILES | O=C(CC(C1=C2)=C(CC)N(CC3=CC=CC=C3)C1=CC=C2OCCCP(O)(O)=O)N | ||
| Formula | C22H27N2O5P | M.Wt | 430.43 |
| 溶解度 | DMF: 30 mg/ml,DMSO: 30 mg/ml,PBS (pH 7.2): 2 mg/ml | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.3233 mL | 11.6163 mL | 23.2326 mL |
| 5 mM | 0.4647 mL | 2.3233 mL | 4.6465 mL |
| 10 mM | 0.2323 mL | 1.1616 mL | 2.3233 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC39772 2,4-Dihydroxybenzaldehyde
- GC50533 HADA
- GC33301 BIX-01338 hydrate (BIX01338 hydrate)
- GC44495 OH-C-Chol
- GC32709 Stibogluconate sodium (Sodium stibogluconate)
- GC50046 RuBi-5-HT
- GC16764 Thiorphan
- GC33816 Ertiprotafib (PTP 112)
- GC16883 Cyromazine
- GC15356 Prion Protein 106-126 (human)
- GC11705 Nintedanib (BIBF 1120)
- GC32634 Benzthiazide
- GC31039 RPR104632
- GC43876 Hydroxy Bosentan
- GC34479 AZ PFKFB3 26
- GC40827 ML-226
- GC44059 LG 100268
レビュー
Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *